These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 2570653
1. TSH binding-inhibiting antibodies in hyperthyroidism: relationship to clinical signs and hormone levels. Benker G, Kotulla P, Kendall-Taylor P, Emrich D, Reinwein D. Clin Endocrinol (Oxf); 1989 Jan; 30(1):19-28. PubMed ID: 2570653 [Abstract] [Full Text] [Related]
2. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease. Yamano Y, Takamatsu J, Sakane S, Hirai K, Kuma K, Ohsawa N. Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368 [Abstract] [Full Text] [Related]
3. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease. Morita S, Izumi M, Nagataki S. Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588 [Abstract] [Full Text] [Related]
4. 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb). Hensen J, Kotulla P, Finke R, Badenhoop K, Koppenhagen K, Meinhold H, Schleusener H. J Endocrinol Invest; 1984 Jun; 7(3):215-20. PubMed ID: 6147377 [Abstract] [Full Text] [Related]
5. [A study of biological and histological criteria of thyroid autoimmunity in diffuse goiters with hyperthyroidism]. Leprat F, Felicie-Dellan E, Trouette H, Latapie MJ, Masson B, De Mascarel A, Latapie JL, Roger P. Ann Endocrinol (Paris); 1997 Jun; 58(5):393-8. PubMed ID: 9685997 [Abstract] [Full Text] [Related]
6. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K. Clin Endocrinol (Oxf); 1998 Apr; 48(4):445-53. PubMed ID: 9640411 [Abstract] [Full Text] [Related]
7. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection. Yokoyama N, Izumi M, Katamine S, Nagataki S. J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934 [Abstract] [Full Text] [Related]
8. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study]. Reinwein D, Benker G, König MP, Pinchera A, Schatz H, Schleusener H. Schweiz Med Wochenschr; 1987 Aug 22; 117(34):1245-55. PubMed ID: 3672070 [Abstract] [Full Text] [Related]
9. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period. Momotani N, Noh J, Ishikawa N, Ito K. J Clin Endocrinol Metab; 1994 Jul 22; 79(1):285-9. PubMed ID: 7913091 [Abstract] [Full Text] [Related]
10. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor. Macchia E, Concetti R, Carone G, Borgoni F, Fenzi GF, Pinchera A. Clin Endocrinol (Oxf); 1988 Feb 22; 28(2):147-56. PubMed ID: 2901922 [Abstract] [Full Text] [Related]
11. Response to methimazole in Graves' disease. The European Multicenter Study Group. Benker G, Vitti P, Kahaly G, Raue F, Tegler L, Hirche H, Reinwein D. Clin Endocrinol (Oxf); 1995 Sep 22; 43(3):257-63. PubMed ID: 7586593 [Abstract] [Full Text] [Related]
12. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism. Hörmann R, Hobelsberger A, Saller B, Mann K. Klin Wochenschr; 1986 Oct 31; 64(21):1097-100. PubMed ID: 2879958 [Abstract] [Full Text] [Related]
13. Clinical role of TSH binding inhibiting antibodies (TBIAb) assay. Rubello D, Girelli ME, Piccolo M, Franzelin F, Betterle C, Busnardo B. J Nucl Med Allied Sci; 1990 Oct 31; 34(1):29-33. PubMed ID: 2384822 [Abstract] [Full Text] [Related]
14. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K. J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094 [Abstract] [Full Text] [Related]
15. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodies. Hensen J, Kotulla P, Finke R, Bogner U, Badenhoop K, Meinhold H, Schleusener H. J Clin Endocrinol Metab; 1984 Jun 06; 58(6):980-7. PubMed ID: 6144692 [Abstract] [Full Text] [Related]
16. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid; 2000 Sep 06; 10(9):809-13. PubMed ID: 11041459 [Abstract] [Full Text] [Related]
17. T3 releasing activity by Graves' sera from Graves' thyroid in vitro. Hoermann R, Mueller R, Saller B, Mann K. Acta Endocrinol (Copenh); 1986 Apr 06; 111(4):487-93. PubMed ID: 2871685 [Abstract] [Full Text] [Related]
18. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease. Kashiwai T, Tada H, Watanabe Y, Shimaoka Y, Yagoro A, Hidaka Y, Fujikado T, Amino N. Thyroid; 1998 Oct 06; 8(10):881-5. PubMed ID: 9827654 [Abstract] [Full Text] [Related]
19. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W, Man N, Li YS, Shan ZY, Teng WP. Zhonghua Nei Ke Za Zhi; 2006 Feb 06; 45(2):95-9. PubMed ID: 16624113 [Abstract] [Full Text] [Related]
20. The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients. Reinwein D, Benker G, König MP, Pinchera A, Schatz H, Schleusener A. J Endocrinol Invest; 1988 Mar 06; 11(3):193-200. PubMed ID: 3372959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]